Sharemaestro Newsreel

ICU Medical Inc (ICUI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of ICU Medical Inc (ICUI), noting its current valuation score of 8.38, ranking 90th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of 89.70 and mentions that relevant data for P/B, P/S, and …

L1 Capital funds sell 714,138 Anteris Technologies Global Corp. (AVR)

Funds managed by L1 Capital Pty Ltd, a 10% owner of Anteris Technologies Global Corp. (AVR), recently sold a total of 714,138 shares of common stock. These sales occurred on July 29 and 30, 2026, with prices ranging from $8.03 to $8.20 per share, …

OraSure Technologies Inc (OSUR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for OraSure Technologies Inc (OSUR), detailing its current risk score, industry ranking, and beta value. It includes various financial metrics such as volatility, maximum drawdown, Sharpe Ratio, and liquidity indicators. The report also notes the neutral impact of …

Sanara MedTech Inc. (SMTI) filer’s amended 13G shows exit from share ownership

An amended Schedule 13G filing for Sanara MedTech Inc. (SMTI) indicates that investment advisor Christopher M. Plahm, along with Tall Pines Capital, LLC, and Stonebridge Wealth Management, LLC, no longer beneficially own shares in the company. The filing reports 0 shares owned, representing 0.0% …

Investors in Embecta Corp. (EMBC): Protect Your Rights - Contact Levi & Korsinsky Before August 17, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its financial …

Precision Trading with Lemaitre Vascular Inc. (LMAT) Risk Zones

This article from Stock Traders Daily provides a detailed analysis of Lemaitre Vascular Inc. (LMAT) focusing on precision trading strategies and risk zones. It highlights near-term strong sentiment, mid-term neutrality, and long-term positive bias, along with specific entry, target, and stop-loss levels for different …

ICU Medical, Inc. Revenue Breakdown – FWB:IC7

ICU Medical, Inc. (FWB:IC7) generated a total revenue of ‪1.88 billion EUR last year. The Consumables segment was the top performer, contributing ‪944.33 million EUR, while the United States was the largest regional contributor with ‪1.15 billion EUR in revenue. This article details the …

AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for AngioDynamics Inc (ANGO), highlighting its current risk score, industry ranking, and beta value. It details the stock's volatility, maximum drawdown, and return metrics over various periods, emphasizing its tendency to underperform in up-trending markets and experience smaller …

AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of AngioDynamics Inc (ANGO), stating its current valuation score is 7.33, ranking 152 out of 199 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -19.48, which is significantly below its recent high. It also …

Sei Investments Co. Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT

Sei Investments Co. increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 30.7% in the first quarter, now holding 136,674 shares valued at $14.92 million. Other

Envista Holdings Number of Employees 2026 | Employee Count & Headcount Data

Envista Holdings Corp. (NVST) had approximately 12,067 employees worldwide as of March 2026, marking a 1.5% decline from 2023. Despite this reduction in headcount, the company is actively hiring, with 564 active job postings in 2026. The article provides detailed breakdowns of employee count …

NexGel Updates CEO Employment Terms and Incentive Plan

NexGel Inc. announced updates to President and CEO Adam Levy's employment terms, including a new annual base salary of $375,000, a 2026 bonus structure tied to performance and EBITDA targets, and a grant of options for up to 160,000 shares. The agreement, which replaces …

Dayah Capital LLC Takes Position in AptarGroup, Inc. $ATR

Dayah Capital LLC has acquired a new stake in AptarGroup, Inc. (NYSE:ATR), purchasing 59,000 shares valued at approximately $7.4 million, making it their 10th largest position. AptarGroup received a "Moderate Buy" consensus rating from analysts, with a target price of $170.80, and exceeded its …

Align Technology (ALGN) Stock Slides As Scanner Reset Clouds Aligner Strength

Align Technology's stock fell 3.7% following its Q2 2026 earnings report, despite a strong performance in its clear aligner segment with record case volumes and improved operating margins. The decline was largely attributed to a weaker Systems and Services business, which saw revenue decrease …

Does Expanding Medline Sinclair Partnership in Canada Strengthen DENTSPLY SIRONA's (XRAY) Digital Dentistry Edge?

DENTSPLY SIRONA Inc. is expanding its partnership with Medline Sinclair in Canada, allowing the distributor to offer DENTSPLY SIRONA's full technology portfolio, not just consumables, starting September 1, 2026. This move aims to broaden access to DENTSPLY SIRONA's digital dentistry solutions across Canada, leveraging …

Solventum Number of Employees 2026 | Employee Count & Headcount Data

Solventum Corp. (SOLV) had approximately 20,286 employees worldwide as of March 2026, marking a 367.6% growth since 2023. The company is actively hiring, with 874 active job postings in 2026, and its workforce is concentrated in the United States, Germany, and Poland. The average …

Intuitive Surgical Price Target Announced at $931.00/Share by HSBC

HSBC has set a price target of $931.00 per share for Intuitive Surgical (NASDAQ:ISRG). This new target suggests a potential upside for the company's stock. Investors and market watchers will likely consider this analyst forecast when evaluating ISRG.

[8-K] APTARGROUP, INC. Reports Material Event

APTARGROUP, INC. (NYSE:ATR) has filed an 8-K report detailing its second-quarter 2026 results. The company reported a 6% increase in sales to over $1 billion for the first time, but net income and adjusted EBITDA margins declined compared to the prior year. Aptar returned …

Nexgel Inc (NXGL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Nexgel Inc (NXGL), highlighting its beta value of 0.74, indicating lower volatility compared to the S&P 500. The company's current risk assessment score is 2.23, placing it 130th out of 155 in the Pharmaceuticals industry. The analysis …

BioLife Solutions Inc (BLFS) Valuation: PE, PB & Fair Value Analysis

BioLife Solutions Inc (BLFS) currently has a valuation score of 8.75, placing it 62nd out of 199 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -508.27, which is significantly below its recent high and slightly above its recent low. Other …

Merit Medical Systems (NASDAQ:MMSI) Announces Quarterly Earnings Results, Beats Expectations By $0.23 EPS

Utah Medical Products (NASDAQ:UTMD) Share Price Crosses Above 200-Day Moving Average - Time to Sell?

Bausch + Lomb (BLCO) Lifts 2026 Revenue Guidance, Is The Stock Still 57% Undervalued?

Alcon AG (ALC) Financial Health: Profitability & Balance Sheet Analysis

AptarGroup, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:ATR) 2026-07-31

Envista Holdings (NVST) Could Be 6% Undervalued On Q2 Earnings Focus

Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries

Stevanato Group's Alina® pen injector platform has received marketing authorizations in multiple European countries for liraglutide-based combination products used in diabetes and weight management therapies. This expansion signifies broader commercial adoption of the Alina® 30 and Alina® 50 variants, highlighting Stevanato Group's commitment to …

SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36

H.C. Wainwright has downgraded SANARA MEDTECH INC (SMTI.O) from a "Buy" rating to "Neutral" and simultaneously lowered its target price to $35 from $36. This change in rating and price target reflects the analyst's updated view on the company's prospects. The article reiterates this …

Anteris Technologies Trading Paused Pending a Further Announcement

Trading in Anteris Technologies Global Corp. (ASX:AVR) securities has been temporarily paused by ASX Supervision as of July 31, 2026, pending a further announcement. The reason for the pause and the content or timing of the upcoming announcement were not disclosed by the company. …

ASX Suspends Trading of Anteris Technologies Shares Pending Upcoming Announcement

The ASX has temporarily suspended trading of Anteris Technologies Global Corp. (ASX:AVR) shares as of July 31, 2026. This suspension is in anticipation of an upcoming market announcement from the company. The article, originating from Kalkine Media, requires users to log in or create …

Envista Holdings Corp (NVST) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Envista Holdings Corp (NVST), highlighting its current valuation score of 7.77 within the Healthcare Equipment & Supplies industry. It details the company's P/E ratio, noting its position relative to recent highs and lows, and mentions that P/B, …

Baxter International Inc To Go Ex-Dividend On August 28th, 2026 With 0.01 USD Dividend Per Share

Baxter International Inc. (NYSE: BAX) is scheduled to go ex-dividend on August 28th, 2026. Shareholders will receive a dividend of 0.01 USD per share. This information is key for investors looking to receive the upcoming dividend payment.

Anteris Technologies Issues 3,000 CDIs to Raise A$34,500 on Warrant Conversion

Anteris Technologies Global Corp. (ASX:AVR) has issued 3,000 CHESS Depositary Interests (CDIs) following the conversion of unlisted CDI warrants, raising A$34,500. This transaction involves the exercise of existing warrants at A$11.50 each and does not represent a new capital raising initiative. The company specializes …

DENTSPLY SIRONA Inc (XRAY) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of DENTSPLY SIRONA Inc (XRAY), noting its current financial score is 6.13, ranking it 172 out of 199 in the Healthcare Equipment & Supplies industry. Despite a weak overall financial status, the company shows high operating efficiency. …

3 Reasons to Avoid WST and 1 Stock to Buy Instead

West Pharmaceutical Services (WST) stock has recently surged by 43%, but analysts recommend caution due to concerns about its long-term revenue growth, shrinking adjusted operating margin, and declining return on invested capital (ROIC). The article suggests that WST's current valuation of 36.4x forward P/E …

Do Wall Street Analysts Like Baxter International Stock?

Baxter International Inc. (BAX) has experienced significant stock performance fluctuations, underperforming the S&P 500 over the last year but outperforming it year-to-date. The company recently exceeded Q2 FY2026 earnings expectations, revised its full-year guidance upward, and maintains a "Hold" consensus rating from analysts, with …